// App-Quantinova.ai

3729 : Novel radiation mitigators and anticancer drugs

Researchers

Presenter

  • Robert H. Schiestl

Principal Investigators

  • Yelena Rivina

  • Michael Davoren

Medical Centers

  • UCLA Fielding School of Public Health, Los Angeles, CA

  • Stanford Univ, Palo Alto, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Anemia

  • Solid malignancies

Biomarkers

  • DNA Damage Inducible Transcript 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved